Assessing the Ability of An Innovative Screening Method To Identify Proteomic Changes In Cancer Patients- Protocol
Observational Model: Cohort, Time Perspective: Prospective
Number of Participants with a significant cancer fingerprint as measured by NovellusDX Cancer Early Detection test
NovellusDX Cancer Early Detection test will identify participants with significant cancer fingerprint based on tumor protein secretion to the blood circulation in sick subjects.
Yishai Ofran, MD
Rambam MC. Haematology Department
Israel: Ministry of Health